SCHEMBL21480702

SCHEMBL21480702

CCC(C)(C)C(=O)OCc1ccc(NC(C)(C)I)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 5/20 0.35
GAA P10253 2/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RIPK1 Q13546 1/20 0.34
ALDH1A1 P00352 2/20 0.33
ROCK2 O75116 1/20 0.33
NAMPT P43490 1/20 0.33
LMNA P02545 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
POLB P06746 1/20 0.33
PTPN2 P17706 1/20 0.32
PTPN1 P18031 1/20 0.32
PTPRB P23467 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22907349 0.87 MEN1 (0.42) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL21120299 0.87 KMT2A (0.42) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL18646461 0.83 KMT2A (0.38) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL19318311 0.82 KMT2A (0.41) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT
SCHEMBL13296164 0.80 APP (0.41) KMT2AMEN1RIPK1ALDH1A1
SCHEMBL12733146 0.80 ALDH1A1 (0.44) KMT2AMEN1L3MBTL1MAPTRAB9A
SCHEMBL2742136 0.80 MEN1 (0.50) KMT2AMEN1ALDH1A1LMNACA1
SCHEMBL12116550 0.79 HPGD (0.46) MAPTGAARAB9AALDH1A1CA1
SCHEMBL10159813 0.79 PPARG (0.44) KMT2AMEN1SMN1; SMN2L3MBTL1RAB9A
SCHEMBL23899582 0.78 KMT2A (0.42) KMT2AMEN1SMN1; SMN2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019197506-A9 AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT GENMAB A/S (DK) 2019-12-05 WO disclosed
WO-2019197506-A1 AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT GENMAB A/S (DK) 2019-10-17 WO disclosed